Dow Down 0.25% Nasdaq Down 0.26%

Aeterna Zentaris Inc. (AEZS)

-NasdaqCM
1.40 0.07(5.26%) Aug 28, 3:59PM EDT
|Pre-Market : 1.48 Up 0.08 (5.71%) 8:51AM EDT - Nasdaq Real Time Price
Prev Close:1.33
Open:1.33
Bid:1.45 x 500
Ask:1.47 x 100
1y Target Est:3.24
Beta:2.05
Next Earnings Date:N/A
Day's Range:1.33 - 1.42
52wk Range:0.99 - 1.75
Volume:3,567,928
Avg Vol (3m):772,403
Market Cap:81.04M
P/E (ttm):87.50
EPS (ttm):0.02
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for AEZS

Comparison

Symbol% ChgMkt Cap
AEZSUp 5.26%81.04M
CELG75.71B
ENMDN/A

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):4,528.81
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.59
Quarterly EPS Est (Sep-14) :-0.16
Mean Recommendation*:2.4
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Aeterna Zentaris Inc., a specialty biopharmaceutical company, is focused on developing and commercializing novel treatments in oncology and endocrinology. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback